The prevalence of non-fatal overdose among people who inject drugs: A multi-stage systematic review and meta-analysis.

[1]  P. Dietze,et al.  Drug overdose in the ED: a record linkage study examining emergency department ICD-10 coding practices in a cohort of people who inject drugs , 2018, BMC Health Services Research.

[2]  T. Clausen,et al.  Ambulance-Attended Opioid Overdoses: An Examination into Overdose Locations and the Role of a Safe Injection Facility , 2018, Substance abuse.

[3]  S. Allen,et al.  Safe and unsafe spaces: Non-fatal overdose, arrest, and receptive syringe sharing among people who inject drugs in public and semi-public spaces in Baltimore City. , 2018, The International journal on drug policy.

[4]  S. Lenton,et al.  Findings and lessons learnt from implementing Australia's first health service based take‐home naloxone program , 2018, Drug and alcohol review.

[5]  R. Grieve,et al.  Cost-Effectiveness of Take-Home Naloxone for the Prevention of Overdose Fatalities among Heroin Users in the United Kingdom. , 2018, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[6]  R. Bruno,et al.  Knowledge of Opioid Overdose and Attitudes to Supply of Take-Home Naloxone Among People with Chronic Noncancer Pain Prescribed Opioids , 2018, Pain medicine.

[7]  H. Thiede,et al.  Utilization of Buprenorphine and Methadone among Opioid users who Inject Drugs , 2018, Substance abuse.

[8]  L. Cardoso,et al.  The Willingness of People who Inject Drugs in Boston to use a Supervised Injection Facility , 2018, Substance abuse.

[9]  M. Golden,et al.  Increasing methamphetamine injection among non-MSM who inject drugs in King County, Washington. , 2018, Drug and alcohol dependence.

[10]  J. Leung,et al.  Global, regional, and country-level coverage of interventions to prevent and manage HIV and hepatitis C among people who inject drugs: a systematic review , 2017, The Lancet. Global health.

[11]  J. Leung,et al.  Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic review , 2017, The Lancet. Global health.

[12]  D. D. Des Jarlais,et al.  Intravenous heroin use in Haiphong, Vietnam: Need for comprehensive care including methamphetamine use-related interventions. , 2017, Drug and alcohol dependence.

[13]  Eyal Oren,et al.  Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 , 2017, Lancet.

[14]  E. McCarthy,et al.  Hospitalizations, costs and outcomes associated with heroin and prescription opioid overdoses in the United States 2001–12 , 2017, Addiction.

[15]  Guohua Li,et al.  Risk markers for fatal and non-fatal prescription drug overdose: a meta-analysis , 2017, Injury Epidemiology.

[16]  V. Hope,et al.  The extent of and factors associated with self-reported overdose and self-reported receipt of naloxone among people who inject drugs (PWID) in England, Wales and Northern Ireland. , 2017, The International journal on drug policy.

[17]  S. Rourke,et al.  Acceptability and design preferences of supervised injection services among people who inject drugs in a mid-sized Canadian City , 2017, Harm Reduction Journal.

[18]  William T. Robinson,et al.  Brief Report: Nonfatal Overdose Events Among Persons Who Inject Drugs Findings From Seven National HIV Behavioral Surveillance Cities 2009 & 2012 , 2017, Journal of acquired immune deficiency syndromes.

[19]  L. Degenhardt,et al.  Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies , 2017, British Medical Journal.

[20]  Lisa Raville,et al.  Heroin and Methamphetamine Injection: An Emerging Drug Use Pattern , 2017, Substance use & misuse.

[21]  T. Saliuk,et al.  Trends in Injection Risk Behaviors among People Who Inject Drugs and the Impact of Harm Reduction Programs in Ukraine, 2007–2013 , 2017, Journal of Urban Health.

[22]  N. Bannert,et al.  High variability of HIV and HCV seroprevalence and risk behaviours among people who inject drugs: results from a cross-sectional study using respondent-driven sampling in eight German cities (2011–14) , 2016, BMC Public Health.

[23]  M. Čivljak,et al.  HIV and hepatitis C prevalence, and related risk behaviours among people who inject drugs in three cities in Croatia: Findings from respondent-driven sampling surveys. , 2016, The International journal on drug policy.

[24]  D. Prybylski,et al.  HIV prevalence and risk behaviors among people who inject drugs in Songkhla, Thailand: A respondent-driven sampling survey. , 2016, The International journal on drug policy.

[25]  Huiru Dong,et al.  Non-fatal overdose as a risk factor for subsequent fatal overdose among people who inject drugs. , 2016, Drug and alcohol dependence.

[26]  R. Heimer,et al.  Prevention knowledge, risk behaviours and seroprevalence among nonurban injectors of southwest Connecticut. , 2016, Drug and alcohol review.

[27]  A. Impinen,et al.  Assessment of health services for people who use drugs in Central Asia: findings of a quantitative survey in Kazakhstan and Kyrgyzstan , 2016, Harm Reduction Journal.

[28]  O. Levina,et al.  Emergence of methadone as a street drug in St. Petersburg, Russia. , 2016, The International journal on drug policy.

[29]  Diana L. Gustafson,et al.  Does the public receive and adhere to boil water advisory recommendations? A cross-sectional study in Newfoundland and Labrador, Canada , 2015, BMC Public Health.

[30]  M. Tyndall,et al.  Risk environments facing potential users of a supervised injection site in Ottawa, Canada , 2015, Harm Reduction Journal.

[31]  S. Galea,et al.  Worldwide Prevalence and Trends in Unintentional Drug Overdose: A Systematic Review of the Literature. , 2015, American journal of public health.

[32]  Christopher M. Jones,et al.  Emergency Department Visits and Overdose Deaths From Combined Use of Opioids and Benzodiazepines. , 2015, American journal of preventive medicine.

[33]  Forrest W. Crawford,et al.  HIV Prevalence Among People Who Inject Drugs in Greater Kuala Lumpur Recruited Using Respondent-Driven Sampling , 2015, AIDS and Behavior.

[34]  R. Westergaard,et al.  High uptake of naloxone-based overdose prevention training among previously incarcerated syringe-exchange program participants. , 2015, Drug and alcohol dependence.

[35]  S. Whitehead,et al.  Diverse HIV epidemics among people who inject drugs in Thailand: evidence from respondent-driven sampling surveys in Bangkok and Chiang Mai. , 2015, Drug and alcohol dependence.

[36]  Jasmina Burdzovic Andreas,et al.  Illicit use of opioid substitution drugs: prevalence, user characteristics, and the association with non-fatal overdoses. , 2015, Drug and alcohol dependence.

[37]  Meredith C Meacham.  Polydrug use and risk of HIV and overdose among people who inject drugs in San Diego, California, and Tijuana, Baja California, Mexico , 2015 .

[38]  A. Ambekar,et al.  Type of opioids injected: does it matter? A multicentric cross-sectional study of people who inject drugs. , 2015, Drug and alcohol review.

[39]  E. Wood,et al.  Compulsory drug detention and injection drug use cessation and relapse in Bangkok, Thailand. , 2015, Drug and alcohol review.

[40]  C. Camargo,et al.  Trends in U.S. emergency department visits for opioid overdose, 1993-2010. , 2014, Pain medicine.

[41]  P. Chou,et al.  Prevalence and factors associated with HIV infection among injection drug users at methadone clinics in Taipei, Taiwan , 2014, BMC Public Health.

[42]  S. Ojha,et al.  ‘South Asian cocktail’ - the concurrent use of opioids, benzodiazepines and antihistamines among injecting drug users in Nepal and associations with HIV risk behaviour , 2014, Harm Reduction Journal.

[43]  M. Brugal,et al.  Overdose prevention in injecting opioid users: the role of substance abuse treatment and training programs. , 2014, Gaceta sanitaria.

[44]  Khodabakhsh Ahmadi,et al.  Having Multiple Sexual Partners among Iranian Intra-Venous Drug Users , 2013, Front. Psychiatry.

[45]  Dustin B. Stephens.  Primary and secondary prevention of hepatitis C virus among rural appalachian people who use drugs , 2014 .

[46]  A. Bretteville-Jensen,et al.  Is opioid substitution treatment beneficial if injecting behaviour continues? , 2013, Drug and alcohol dependence.

[47]  R. Hoffman,et al.  Experimental Treatments for Cocaine Toxicity: A Difficult Transition to the Bedside , 2013, The Journal of Pharmacology and Experimental Therapeutics.

[48]  O. Levina,et al.  Moderate/heavy alcohol use and HCV infection among injection drug users in two Russian cities. , 2013, Drug and alcohol dependence.

[49]  J. Glanz,et al.  National trends in pharmaceutical opioid related overdose deaths compared to other substance related overdose deaths: 1999-2009. , 2013, Drug and alcohol dependence.

[50]  S. Sullivan,et al.  Cost-effectiveness of distributing naloxone to heroin users for lay overdose reversal in Russian cities , 2013, Journal of medical economics.

[51]  A. A. Turki,et al.  New Evidence on the HIV Epidemic in Libya: Why Countries Must Implement Prevention Programs Among People Who Inject Drugs , 2013, Journal of acquired immune deficiency syndromes.

[52]  K. O’grady,et al.  Opioid agonist treatments and heroin overdose deaths in Baltimore, Maryland, 1995-2009. , 2013, American journal of public health.

[53]  C. Bucello,et al.  Mortality among people who inject drugs: a systematic review and meta-analysis. , 2013, Bulletin of the World Health Organization.

[54]  Sean D. Sullivan,et al.  Cost-Effectiveness of Distributing Naloxone to Heroin Users for Lay Overdose Reversal , 2013, Annals of Internal Medicine.

[55]  M. Berglund,et al.  Respondent-driven sampling in a syringe exchange setting , 2012, Scandinavian journal of public health.

[56]  S. Verma,et al.  Gender differences in hepatitis C seroprevalence and suboptimal vaccination and hepatology services uptake amongst substance misusers , 2012, Journal of medical virology.

[57]  E. Wood,et al.  Factors associated with methadone treatment among injection drug users in Bangkok, Thailand. , 2012, Journal of substance abuse treatment.

[58]  J. Hahn,et al.  Mortality among young injection drug users in San Francisco: a 10-year follow-up of the UFO study. , 2012, American journal of epidemiology.

[59]  A. Rahimi-Movaghar,et al.  Factors Correlated With Hepatitis C and B Virus Infections Among Injecting Drug Users in Tehran, IR Iran , 2012, Hepatitis monthly.

[60]  Erin E. Bonar,et al.  Using the health belief model to predict injecting drug users' intentions to employ harm reduction strategies. , 2011, Addictive behaviors.

[61]  J. Rich,et al.  Illicit Use of Buprenorphine/Naloxone Among Injecting and Noninjecting Opioid Users , 2011, Journal of addiction medicine.

[62]  L. Johnston,et al.  High HIV and hepatitis C prevalence amongst injecting drug users in Mauritius: findings from a population size estimation and respondent driven sampling survey. , 2011, The International journal on drug policy.

[63]  K. Mills,et al.  Rates and correlates of mortality amongst heroin users: findings from the Australian Treatment Outcome Study (ATOS), 2001-2009. , 2011, Drug and alcohol dependence.

[64]  J. Havens,et al.  Individual and network factors associated with non-fatal overdose among rural Appalachian drug users. , 2011, Drug and alcohol dependence.

[65]  M. Berglund,et al.  Efficacy of mobile telephone contact for follow-up in injecting heroin users , 2011, The American journal of drug and alcohol abuse.

[66]  L. Degenhardt,et al.  Mortality among regular or dependent users of heroin and other opioids: a systematic review and meta-analysis of cohort studies. , 2011, Addiction.

[67]  C. Maynard,et al.  Risk Factors for Nonfatal Overdose at Seattle-Area Syringe Exchanges , 2011, Journal of Urban Health.

[68]  R. Ahas,et al.  Emergent properties of HIV risk among injection drug users in Tallinn, Estonia: synthesis of individual and neighbourhood-level factors , 2010, Sexually Transmitted Infections.

[69]  L. Lundgren,et al.  Needle Sharing Among Puerto Rican Injection Drug Users in Puerto Rico and Massachusetts: Place of Birth and Residence Matter , 2010, Substance use & misuse.

[70]  J. Kaldor,et al.  The impact of a supervised injecting facility on ambulance call-outs in Sydney, Australia. , 2010, Addiction.

[71]  E. Wood,et al.  High rates of midazolam injection among drug users in Bangkok, Thailand , 2010, Harm reduction journal.

[72]  Peter C. Britton,et al.  Non-fatal overdose in the 12 months following treatment for substance use disorders. , 2010, Drug and alcohol dependence.

[73]  T. Rhodes,et al.  HIV infection and risk behaviour of primary fentanyl and amphetamine injectors in Tallinn, Estonia: implications for intervention. , 2010, The International journal on drug policy.

[74]  A. Hatzakis,et al.  Seroepidemiology of human herpesvirus 8 (HHV-8) infection in injecting drug users , 2009, Epidemiology and Infection.

[75]  J. Amin,et al.  High HIV testing and low HIV prevalence among injecting drug users attending the Sydney Medically Supervised Injecting Centre , 2009, Australian and New Zealand journal of public health.

[76]  D. Jolley,et al.  Improved response by peers after witnessed heroin overdose in Melbourne. , 2009, Drug and alcohol review.

[77]  J. Kaldor,et al.  Process and predictors of drug treatment referral and referral uptake at the Sydney Medically Supervised Injecting Centre. , 2008, Drug and alcohol review.

[78]  Matthew Hickman,et al.  Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review , 2008, The Lancet.

[79]  D. Jolley,et al.  Attitudes of Australian Heroin Users to Peer Distribution of Naloxone for Heroin Overdose: Perspectives on Intranasal Administration , 2008, Journal of Urban Health.

[80]  J. Kimber,et al.  An examination of the quality of life among rural and outer metropolitan injecting drug users in NSW, Australia , 2008 .

[81]  D. Celentano,et al.  A Cross-Sectional Study on Prevalence of Non-Fatal Drug Overdose and Associated Risk Characteristics Among Out-of-Treatment Injecting Drug Users in North Vietnam , 2008, Substance use & misuse.

[82]  J. Montaner,et al.  Crystal methamphetamine use associated with non-fatal overdose among a cohort of injection drug users in Vancouver. , 2008, Public health.

[83]  R. Allard,et al.  Low perceived benefits and self-efficacy are associated with hepatitis C virus (HCV) infection-related risk among injection drug users. , 2008, Social science & medicine.

[84]  Federica Vigna-Taglianti,et al.  Risk of fatal overdose during and after specialist drug treatment: the VEdeTTE study, a national multi-site prospective cohort study. , 2007, Addiction.

[85]  J. Montaner,et al.  Predictors of non-fatal overdose among a cohort of polysubstance-using injection drug users. , 2007, Drug and alcohol dependence.

[86]  J. Elmore,et al.  Release from prison--a high risk of death for former inmates. , 2007, The New England journal of medicine.

[87]  M. Farrell,et al.  Drug-related mortality and fatal overdose risk: Pilot cohort study of heroin users recruited from specialist drug treatment sites in London , 2003, Journal of Urban Health.

[88]  J. Montaner,et al.  Safer injection facility use and syringe sharing in injection drug users , 2005, The Lancet.

[89]  Shane Darke,et al.  Non-fatal cocaine overdose among injecting and non-injecting cocaine users in Sydney, Australia. , 2004, Addiction.

[90]  J. Montaner,et al.  Changes in public order after the opening of a medically supervised safer injecting facility for illicit injection drug users , 2004, Canadian Medical Association Journal.

[91]  J. Montaner,et al.  Rationale for evaluating North America's first medically supervised safer-injecting facility. , 2004, The Lancet. Infectious diseases.

[92]  R. Mattick,et al.  The ratio of non-fatal to fatal heroin overdose. , 2003, Addiction.

[93]  J. Ornato,et al.  Coronary angiographic findings in patients with cocaine-associated chest pain. , 2003, The Journal of emergency medicine.

[94]  C. Tennant,et al.  Cocaine use and cardiovascular complications , 2002, The Medical journal of Australia.

[95]  C. Day,et al.  Morbidity associated with non-fatal heroin overdose. , 2002, Addiction.

[96]  L. Hillis,et al.  Cardiovascular complications of cocaine use. , 2001, The New England journal of medicine.

[97]  W. Hall,et al.  Heroin overdose: causes and consequences. , 2001, Addiction.

[98]  Raimondo Bruno,et al.  Australian Drug Trends 2004: Findings from the Illicit Drug Reporting System (IDRS) , 2006 .

[99]  S. Darke,et al.  Heroin-related deaths in New South Wales, Australia, 1992-1996. , 2000, Drug and alcohol dependence.

[100]  G. Rumbold,et al.  Ambulance attendance at heroin overdose in Melbourne: the establishment of a database of Ambulance Service records , 2000 .

[101]  J. White,et al.  Mechanisms of fatal opioid overdose. , 1999, Addiction.

[102]  R. Ali,et al.  Experience of non-fatal overdose among heroin users in Adelaide, Australia: circumstances and risk perceptions. , 1998, Addiction.

[103]  S. Darke,et al.  Fatal heroin 'overdose': a review. , 1996, Addiction.

[104]  A. P. Boyes.  Repetition of overdose: a retrospective 5-year study. , 1994, Journal of advanced nursing.

[105]  Steven B Karch,et al.  The pathology of drug abuse , 1993 .